Mitoxantrone hinders proteasome exercise along with requests early on energetic and proteomic adjustments to HL-1 cardiomyocytes at clinically relevant amounts.
Mitoxantrone hinders proteasome exercise along with requests early on energetic and proteomic adjustments to HL-1 cardiomyocytes at clinically relevant amounts.